Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 150 of 6914 publications.
Turk D, Boeri M, Abraham L, Hauber B, Atkinson J, Bushmakin AG, Cappelleri JC, Russo L, Viktrup L, Walsh DA. Patient preferences for attributes of treatments for chronic pain associated with osteoarthritis pain and chronic low back pain that differentiate nerve-growth factor inhibitors, nonsteroidal anti-inflammatory drugs, and opioids in the US: a Discrete-Choice Experiment (DCE). Presented at the 2019 ACR/ARP Annual Meeting; November 12, 2019. Atlanta, GA. [abstract] Arthritis Rheumatol. 2019 Oct; 71(suppl 10). doi: 10.1002/art.v71.s10.
Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AL, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano C, Williams VSL, Vissing J, Zhang Auberson L, Wu M, de Vera A, Papanicolaou DA, Amato AA, RESILIENT Study Group. Safety and efficacy of intravenous bimagrumab in inclusion body myositis: a phase 2b, randomised, double-blind, placebo-controlled study (RESILIENT). Lancet Neurol. 2019 Sep;18(9):834-44.

Pages